ARCHIVES

FY 1990 Bypass Budget f $2.345 Billion Approved By NCAB; Hammer’s Effort Makes That Possible

This article is from The Cancer Letter archive.

Vol. 14 No. 21 | May 20, 1988

Download PDF Visit The Full Archive

Related Articles

Molecular target Drug Discovery Grants; Unanimously Approved

July 2, 1999

Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter

October 15, 1976

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

In Brief: Goldsmith Named CEO of CancerCare

April 11, 2014

Funding Opportunities. (8-page issue).

May 2, 2003

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012